Polymorphisms risk modeling for vascular toxicity in patients with glioblastoma treated on NRG Oncology/RTOG 0825.

被引：0
|
作者：
Zhou, Renke
Scheurer, Michael E.
Gilbert, Mark R.
Bondy, Melissa
Sulman, Erik P.
Yuan, Ying
Liu, Yanhong
Vera, Elizabeth
Wendland, Merideth M.
Brachman, David
Bearden, James
McGovern, Susan Lynne
Wilson, Steven S.
Judy, Kevin D.
Robins, H. Ian
Hunter, Grant Kirton
Pugh, Stephanie L.
Armstrong, Terri S.
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[4] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA
[5] Willamette Valley Canc Inst, Eugene, OR USA
[6] Univ Arizona, Canc Ctr, Phoenix Accruals Arizona Oncol Serv Fdn, Phoenix, AZ USA
[7] Southeast Canc Control Consortium Inc, CCOP, Winston Salem, NC USA
[8] UPMC Canc Ctr, New Castle, PA USA
[9] Thomas Jefferson Univ, Philadelphia, PA 19107 USA
[10] Univ Wisconsin, Comprehens Canc Ctr, Madison, WI USA
[11] Intermountain Healthcare, Murray, UT USA
[12] NRG Oncol, Philadelphia, PA USA
[13] Univ Texas Hlth Sci Ctr Houston, Sch Nursing, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.2049
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2049
引用
收藏
页数：2
相关论文
共 42 条
  • [31] Risk of Adverse Vascular Events in Newly Diagnosed Glioblastoma Multiforme Patients Treated with Bevacizumab: a Systematic Review and Meta-Analysis
    Li, Xiaoqing
    Huang, Rongzhong
    Xu, Zhongye
    SCIENTIFIC REPORTS, 2015, 5
  • [32] Risk of Adverse Vascular Events in Newly Diagnosed Glioblastoma Multiforme Patients Treated with Bevacizumab: a Systematic Review and Meta-Analysis
    Xiaoqing Li
    Rongzhong Huang
    Zhongye Xu
    Scientific Reports, 5
  • [33] Adjuvant chemotherapy following concurrent chemoradiation (CRT) in patients with high-risk early-stage cervical carcinoma following radical hysterectomy: Results of NRG oncology/RTOG 0724/GOG-0724
    Jhingran, Anuja
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] Conditional Risk and Predictive Factors Associated With Late Toxicity in Patients With Prostate Cancer Treated With External Beam Radiation Therapy Alone in the Randomized Trial RTOG 0126
    Alexander, Gregory S.
    Krc, Rebecca F.
    Assif, James W.
    Sun, Kai
    Molitoris, Jason K.
    Tran, Phuoc
    Rana, Zaker
    Mishra, Mark, V
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (04): : 990 - 998
  • [35] Initial Report of NRG Oncology/RTOG 0232: A Phase 3 Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy With Brachytherapy Alone for Selected Patients With Intermediate-Risk Prostatic Carcinoma
    Prestidge, B. R.
    Winter, K.
    Sanda, M. G.
    Amin, M.
    Bice, W. S., Jr.
    Michalski, J.
    Ibbott, G. S.
    Crook, J. M.
    Catton, C. N.
    Gay, H. A.
    Donavanik, V.
    Beyer, D. C.
    Frank, S. J.
    Papagikos, M. A.
    Rosenthal, S. A.
    Barthold, H. J. J., II
    Roach, M., III
    Sandler, H. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S4 - S4
  • [36] Long-Term Follow-Up Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Non -Inferiority Study Comparing Two Fractionation Schedules in Patients with Favorable-Risk Prostate Cancer
    Lee, W. R.
    Dignam, J. J.
    Amin, M.
    Bruner, D. W.
    Low, D.
    Swanson, G. P.
    Shah, A. B.
    D'Souza, D. P.
    Michalski, J. M.
    Dayes, I.
    Seaward, S. A.
    Hall, W. A.
    Nguyen, P. L.
    Pisansky, T. M.
    Faria, S. L.
    Chen, Y.
    Rodgers, J.
    Sandler, H. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S3 - S4
  • [37] Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group-174 Phase III Trial
    You, Benoit
    Deng, Wei
    Henin, Emilie
    Oza, Amit
    Osborne, Raymond
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (01) : 208 - 215
  • [38] Socio-demographic predictors of biochemical failure and survival among high risk patients treated on radiation therapy oncology group (RTOG) prostate cancer trials: A meta-analysis
    Roach, M.
    Moughan, J.
    Movsas, B.
    Konski, A.
    Hanks, G.
    Cox, J.
    Watkins-Bruner, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S204 - S204
  • [39] Progression-free survival (PFS) and cardiac-toxicity-adjusted-PFS (CTA-PFS) as predictors of overall survival (OS) in locally advanced non-small cell lung cancers (LA-NSCLC) treated with concurrent chemoradiation (CCRT): A secondary analysis of NRG Oncology RTOG 0617.
    Hu, Chen
    Machtay, Mitchell
    Dignam, James J.
    Paulus, Rebecca
    Bradley, Jeffrey D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [40] TREATMENT Toxicity in Adolescents and Young ADULT (AYA) PATIENTS COMPARED with Younger PATIENTS TREATED for HIGH RISK B-Precursor ACUTE LYMPHOBLASTIC LEUKEMIA (HR-ALL): A REPORT From the CHILDREN'S Oncology GROUP STUDY AALL0232
    Larsen, Eric C.
    Salzer, Wanda
    Nachman, James
    Devidas, Meenakshi
    Freyer, David R.
    Raetz, Elizabeth A.
    Winick, Naomi
    Hunger, Stephen P.
    Carroll, William L.
    BLOOD, 2011, 118 (21) : 655 - 655
12345